Education
About Us
Working with TipRanks
Follow Us
Fuso Pharmaceutical Industries,Ltd. (JP:4538)
:4538
RESEARCH TOOLSreports
Total Valuation
Fuso Pharmaceutical Industries,Ltd. has a market cap or net worth of ¥19.97B. The enterprise value is ¥43.18B.
Market Cap¥19.97B
Enterprise Value¥43.18B
Share Statistics
Fuso Pharmaceutical Industries,Ltd. has 9,451,169 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,451,169
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Fuso Pharmaceutical Industries,Ltd.’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 4.87%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)4.87%
Return on Capital Employed (ROCE)0.09
Revenue Per Employee44.21M
Profits Per Employee2.03M
Employee Count1,370
Asset Turnover0.77
Inventory Turnover2.95
Valuation Ratios
The current PE Ratio of Fuso Pharmaceutical Industries,Ltd. is 6.5. Fuso Pharmaceutical Industries,Ltd.’s PEG ratio is ―.
PE Ratio6.5
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.53
Price to FCF0.00
Price to Operating Cash Flow16.12
PEG Ratio―
Income Statement
In the last 12 months, Fuso Pharmaceutical Industries,Ltd. had revenue of 60.56B and earned 2.78B in profits. Earnings per share was 325.43.
Revenue60.56B
Gross Profit16.53B
Operating Income4.13B
Pretax Income3.77B
Net Income2.78B
EBITDA6.29B
Earnings Per Share (EPS)325.43
Cash Flow
In the last 12 months, operating cash flow was 4.37B and capital expenditures 0.00, giving a free cash flow of 4.37B billion.
Operating Cash Flow4.37B
Free Cash Flow4.37B
Free Cash Flow per Share462.17
Dividends & Yields
Fuso Pharmaceutical Industries,Ltd. pays an annual dividend of ¥45, resulting in a dividend yield of 3.6%
Dividend Per Share¥45
Dividend Yield3.6%
Payout Ratio26.84%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.59
52-Week Price Change9.50%
50-Day Moving Average2.14K
200-Day Moving Average2.35K
Relative Strength Index (RSI)77.36
Average Volume (3m)14.71K
Important Dates
Fuso Pharmaceutical Industries,Ltd. upcoming earnings date is Nov 6, 2025, TBA (Confirmed).
Last Earnings DateAug 8, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend DateSep 29, 2025
Financial Position
Fuso Pharmaceutical Industries,Ltd. as a current ratio of 1.37, with Debt / Equity ratio of 54.43%
Current Ratio1.37
Quick Ratio0.94
Debt to Market Cap1.02
Net Debt to EBITDA2.39
Interest Coverage Ratio25.66
Taxes
In the past 12 months, Fuso Pharmaceutical Industries,Ltd. has paid 993.00M in taxes.
Income Tax993.00M
Effective Tax Rate0.26
Enterprise Valuation
Fuso Pharmaceutical Industries,Ltd. EV to EBITDA ratio is 5.71, with an EV/FCF ratio of -6.61.
EV to Sales0.59
EV to EBITDA5.71
EV to Free Cash Flow-6.61
EV to Operating Cash Flow-10.86
Balance Sheet
Fuso Pharmaceutical Industries,Ltd. has ¥6.68B in cash and marketable securities with ¥14.28B in debt, giving a net cash position of ¥7.60B billion.
Cash & Marketable Securities¥6.68B
Total Debt¥14.28B
Net Cash¥7.60B
Net Cash Per Share¥804.03
Tangible Book Value Per Share¥4.58K
Margins
Gross margin is 27.30%, with operating margin of 6.82%, and net profit margin of 4.59%.
Gross Margin27.30%
Operating Margin6.82%
Pretax Margin6.23%
Net Profit Margin4.59%
EBITDA Margin10.39%
EBIT Margin6.50%
Analyst Forecast
The average price target for Fuso Pharmaceutical Industries,Ltd. is ¥2,369.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target¥2,369.00
Price Target Upside4.09% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast8.71%
EPS Growth Forecast-325.91%